Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
Biotech stocks are surging. How investors can play the new drug innovation boom
Source: CNBC
Original reporting
CNBC: read the full reportRelated stories
The Guardian2 outlets
Healey’s first budget to include big devolution package to boost growth
Chancellor will build on Burnham’s promise that local leaders in England will no longer have to ‘come cap in hand to Westminster’ Andy Burnham has promised that local leaders in England will no longer have to come “cap in hand to Westminster” ahead of a fresh drive to devolve spending power in next week’s budget. In his statement on Wednesday, the chancellor, John Healey, will include plans for a new £1.5bn borrowing facility, to be drawn up in collaboration with mayors over the next two years. Continue reading...
CNBC
American embassies tighten security as Iran threat warnings intensify ahead of U.S. midterm elections
A memo from DNI director Jay Clayton said Iran is in the "advanced stages" of planning attacks against Americans.
CNBC
After SpaceX restores high-speed service, Musk claims Ukraine violated Starlink agreement
Ukraine says restrictions on Starlink and Starshield have been lifted, restoring connectivity to fast-moving military systems after disruptions.
CNBC
Democrats, voting-rights groups challenge Trump's bid to block Alaska Senate certification
Lawsuits filed by candidate Mary Peltola and a voters' rights group challenge Trump's preemptive efforts to block a Democratic Senate victory in Alaska.
CNBC
AI funding fears rattle Wall Street. Here's how we're adjusting our portfolio
The rotation out of AI stocks benefited several defensive Club stocks.
CNBC
Fewer people are flying as airfare soars. Here's why airlines aren't worried
Airlines are reporting fewer people flew in the third quarter as airfare surged on fuel costs, but executives say travelers are mostly swallowing higher fares.